These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22050085)

  • 21. Structural basis of antibody inhibition and chemokine activation of the human CC chemokine receptor 8.
    Sun D; Sun Y; Janezic E; Zhou T; Johnson M; Azumaya C; Noreng S; Chiu C; Seki A; Arenzana TL; Nicoludis JM; Shi Y; Wang B; Ho H; Joshi P; Tam C; Payandeh J; Comps-Agrar L; Wang J; Rutz S; Koerber JT; Masureel M
    Nat Commun; 2023 Dec; 14(1):7940. PubMed ID: 38040762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overlapping binding site for the endogenous agonist, small-molecule agonists, and ago-allosteric modulators on the ghrelin receptor.
    Holst B; Frimurer TM; Mokrosinski J; Halkjaer T; Cullberg KB; Underwood CR; Schwartz TW
    Mol Pharmacol; 2009 Jan; 75(1):44-59. PubMed ID: 18923064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and characterization of small molecule functional antagonists of the CCR1 chemokine receptor.
    Hesselgesser J; Ng HP; Liang M; Zheng W; May K; Bauman JG; Monahan S; Islam I; Wei GP; Ghannam A; Taub DD; Rosser M; Snider RM; Morrissey MM; Perez HD; Horuk R
    J Biol Chem; 1998 Jun; 273(25):15687-92. PubMed ID: 9624164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cryo-EM Structure and Biochemical Analysis of the Human Chemokine Receptor CCR8.
    Peng Q; Jiang H; Cheng X; Wang N; Zhou S; Zhang Y; Yang T; Chen Y; Zhang W; Lv S; Nan W; Wang J; Fan GH; Li J; Zhang J
    Biochemistry; 2024 Aug; 63(15):1892-1900. PubMed ID: 38985857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation and extension of the two-site, two-step model for binding and activation of the chemokine receptor CCR1.
    Sanchez J; E Huma Z; Lane JR; Liu X; Bridgford JL; Payne RJ; Canals M; Stone MJ
    J Biol Chem; 2019 Mar; 294(10):3464-3475. PubMed ID: 30567735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In silico characterization of binding mode of CCR8 inhibitor: homology modeling, docking and membrane based MD simulation study.
    Gadhe CG; Balupuri A; Cho SJ
    J Biomol Struct Dyn; 2015; 33(11):2491-510. PubMed ID: 25617117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ghrelin receptor inverse agonists: identification of an active peptide core and its interaction epitopes on the receptor.
    Holst B; Lang M; Brandt E; Bach A; Howard A; Frimurer TM; Beck-Sickinger A; Schwartz TW
    Mol Pharmacol; 2006 Sep; 70(3):936-46. PubMed ID: 16798937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A conserved aromatic lock for the tryptophan rotameric switch in TM-VI of seven-transmembrane receptors.
    Holst B; Nygaard R; Valentin-Hansen L; Bach A; Engelstoft MS; Petersen PS; Frimurer TM; Schwartz TW
    J Biol Chem; 2010 Feb; 285(6):3973-3985. PubMed ID: 19920139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis, and progress toward optimization of potent small molecule antagonists of CC chemokine receptor 8 (CCR8).
    Ghosh S; Elder A; Guo J; Mani U; Patane M; Carson K; Ye Q; Bennett R; Chi S; Jenkins T; Guan B; Kolbeck R; Smith S; Zhang C; LaRosa G; Jaffee B; Yang H; Eddy P; Lu C; Uttamsingh V; Horlick R; Harriman G; Flynn D
    J Med Chem; 2006 May; 49(9):2669-72. PubMed ID: 16640325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of novel non-peptide CCR1 receptor antagonists.
    Ng HP; May K; Bauman JG; Ghannam A; Islam I; Liang M; Horuk R; Hesselgesser J; Snider RM; Perez HD; Morrissey MM
    J Med Chem; 1999 Nov; 42(22):4680-94. PubMed ID: 10579830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The chemokine, CCL3, and its receptor, CCR1, mediate thoracic radiation-induced pulmonary fibrosis.
    Yang X; Walton W; Cook DN; Hua X; Tilley S; Haskell CA; Horuk R; Blackstock AW; Kirby SL
    Am J Respir Cell Mol Biol; 2011 Jul; 45(1):127-35. PubMed ID: 20870892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular mechanism of action of monocyclam versus bicyclam non-peptide antagonists in the CXCR4 chemokine receptor.
    Rosenkilde MM; Gerlach LO; Hatse S; Skerlj RT; Schols D; Bridger GJ; Schwartz TW
    J Biol Chem; 2007 Sep; 282(37):27354-27365. PubMed ID: 17599916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Species selectivity of a small molecule antagonist for the CCR1 chemokine receptor.
    Liang M; Rosser M; Ng HP; May K; Bauman JG; Islam I; Ghannam A; Kretschmer PJ; Pu H; Dunning L; Snider RM; Morrissey MM; Hesselgesser J; Perez HD; Horuk R
    Eur J Pharmacol; 2000 Feb; 389(1):41-9. PubMed ID: 10686294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Orally bioavailable allosteric CCR8 antagonists inhibit dendritic cell, T cell and eosinophil migration.
    Connolly S; Skrinjar M; Rosendahl A
    Biochem Pharmacol; 2012 Mar; 83(6):778-87. PubMed ID: 22209712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unique interaction pattern for a functionally biased ghrelin receptor agonist.
    Sivertsen B; Lang M; Frimurer TM; Holliday ND; Bach A; Els S; Engelstoft MS; Petersen PS; Madsen AN; Schwartz TW; Beck-Sickinger AG; Holst B
    J Biol Chem; 2011 Jun; 286(23):20845-60. PubMed ID: 21402696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LEC induces chemotaxis and adhesion by interacting with CCR1 and CCR8.
    Howard OM; Dong HF; Shirakawa AK; Oppenheim JJ
    Blood; 2000 Aug; 96(3):840-5. PubMed ID: 10910894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of experimental autoimmune encephalomyelitis: effect of altered peptide ligand on chemokine and chemokine receptor expression.
    Fischer FR; Santambrogio L; Luo Y; Berman MA; Hancock WW; Dorf ME
    J Neuroimmunol; 2000 Oct; 110(1-2):195-208. PubMed ID: 11024550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of post-translational CCR8 modifications and their influence on receptor activity.
    Gutiérrez J; Kremer L; Zaballos A; Goya I; Martínez-A C; Márquez G
    J Biol Chem; 2004 Apr; 279(15):14726-33. PubMed ID: 14736884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CCR1/CCL5 interaction promotes invasion of taxane-resistant PC3 prostate cancer cells by increasing secretion of MMPs 2/9 and by activating ERK and Rac signaling.
    Kato T; Fujita Y; Nakane K; Mizutani K; Terazawa R; Ehara H; Kanimoto Y; Kojima T; Nozawa Y; Deguchi T; Ito M
    Cytokine; 2013 Oct; 64(1):251-7. PubMed ID: 23876400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of the CXCR3 chemokine receptor through anchoring of a small molecule chelator ligand between TM-III, -IV, and -VI.
    Rosenkilde MM; Andersen MB; Nygaard R; Frimurer TM; Schwartz TW
    Mol Pharmacol; 2007 Mar; 71(3):930-41. PubMed ID: 17170198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.